Summary
Two years of prescriptions for all the drugs included in the Italian National Formulary by 3,866 general practitioners, in a region of Northern Italy of almost 4 million inhabitants, were analysed to determine the pattern of drug use.
The data (official code and proprietary name of the drug, number of packages prescribed, price of the drug, dispensing pharmacy, and date of dispensing) were collected monthly by retail pharmacies and were recorded and organized in database files.
Quantitative and qualitative profiles of prescription patterns were studied for all the major therapeutic areas. Overall drug prescriptions averaged 600 DDD/1,000 inhabitants/day. Comparison of 1988 and 1989 data showed only a slight increase in total drug prescriptions, but greater changes were detected in certain drug groups, expecially those recently marketed. Overprescription of well-documented drugs, such as H2-antagonists, ACE-inhibitors, calcium antagonists and the HMG-CoA-reductase inhibitors, in comparison to other countries was shown. There was frequent prescribing of drugs devoid of documentation of their clinical efficacy, which were mainly given for clinical conditions lacking a specific treatment, or as placebos for minor disorders.
The data demonstrate the need for educational intervention to improve the quality of drug prescribing habits in primary health care in Italy.
Similar content being viewed by others
References
Baksaas I (1984) Patterns in drug utilization — national and international aspects: antihypertensive drugs. Acta Med Scand 683 [Suppl]: 59–66
Hall RC (1984) Patterns in drug utilization — national and international aspects: drug use in Australia. Acta Med Scand 683 [Suppl]: 79–80
King DJ, Griffiths K (1984) Patterns in drug utilization — national and international aspects: psychoactive drugs 1966–80. Acta Med Scand 683 [Suppl]: 71–77
Griffiths K, McDevitt DG, Andrew M, Baksaas I, Helgeland A, Jervell J, Lunde PKM, Oydvin K, Agenäs I, Bergman U, Rosenqvist U, Sjöqvist F, Wessling A, Wiholm BE (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. Eur J Clin Pharmacol 30: 513–519
Griffiths K, McDevitt DG, Andrew M, Baksaas I, Helgeland A, Jervell J, Lunde PKM, Oydvin K, Agenäs I, Bergman U, Boethius G, de Faire U, Sjöqvist F, Welin L, Wiholm BE, Wilhelmsen L (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. Eur J Clin Pharmacol 30: 521–525
Wessling A (1987) Continuous recording of drug prescribing in Sweden 1974–1983. Methods and examples of utilization data. Eur J Clin Pharmacol 33: 7–13
Wessling A, Boethius G, Sjöqvist F (1990) Prescription monitoring of drug dosage in the county of Jämtland and Sweden as a whole in 1976, 1982 and 1985. Eur J Clin Pharmacol 38: 329–334
Bozzini L, Castellani L, Tognoni G (1988) Analisi e valutazione delle prescrizioni farmaceutiche in una Unità Sanitaria Locale del Veneto negli anni 1984–1985–1986. G It Farm Clin 2: 81–99
Ostino G, Dana Borga A, Todisco E, Maggiorotti P, D'Ambrosio R, Pratichizzo W, Spagnoli A, Pia L, Cavalli R (1988) La prescrizione e l'uso dei farmaci nell'anziano: studio epidemiologico nella medicina generale. G It Farm Clin 2: 121–137
Montanaro N, Vaccheri A, Magrini N, Battilana M (1992) Farmaguida: a databank for the analysis of the Italian drug market and drug utilization in general practice. Eur J Clin Pharmacol 42: 395–399
Nordic Statistics on Medicines (1985) Nordic Drug Index with Classification and Defined Daily Doses. NLN Publication No 15, Uppsala
Lunde PKM, Baksaas I, Halse M, Halvorsen T, Strømmes B, Oydvin K (1979) The methodology of drug utilization studies. In: Bergman U, Grimson A, Wahba AHW, Westerholm B, eds. Studies in drug utilization. WHO Regional Publications. European Series (Copenhagen) 8: 17–28
Bergman U, Sjöqvist F (1984) Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand 683 [Suppl]: 15–22
Anonymous (1989) Osteoporosis: prevention and treatment. Drug Ther Bull 27: 1–4
Bouchier IAD (1990) Gall stones. Br Med J 300: 592–597
Romero M, Tognoni G (1987) Ormoni timici. Informazioni sui farmaci XI: 285–303
Neu HC (1987) Clinical use of the quinolones. Lancet II: 1319–1322
Svensk läkemedelsstatistik 1988 (1989). Apoteksbolaget, Stockholm
Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257–263
Anonymous (1990) More topical NSAIDs: worth the rub? Drug Ther Bull 28: 27–28
O'Doherty DP, Bickerstaff DR, McCloskey EV, Atkins R, Hamdy NAT, Kanis JA (1990) A comparison of the acute effects of subcutaneous and intranasal calcitonin. Clin Sci 78: 215–219
British National Formulary (1989) British Medical Association and Royal Pharmaceutical Society of Great Britain, London
Guyatt GH, Townsend M, Kazim F, Newhouse MT (1987) A controlled trial of ambroxol in chronic bronchitis. Chest 92: 618–620
Spagnoli A, Tognoni G (1983) “Cerebroactive drugs”. Clinical pharmacology and therapeutic role in cerebrovascular disorders. Drugs 26: 44–69
Anonymous (1990) Drugs for Alzheimer's disease. Drug Ther Bull 28: 42–44
Cummings JL (1990) Clinical features and treatment of Alzheimer's disease. Curr Opin Neurol Neurosurg 3: 90–97
Thompson TL, Filley CM, Mitchell WD, Culig KM, Lo Verde M, Byyny RL (1990) Lack of efficacy of hydergine in patients with Alzheimer's disease. N Engl J Med 323: 445–448
Wessling H, Boethius G (1990) Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol 39: 207–210
Anonymous (1991) Choice of cholesterol-lowering drugs. Med Lett 33: 1–4
O'Connor, Feely J, Shepherd J (1990) Lipid lowering drugs. Br Med J 300: 667–672
Levy R (1990) Are drugs targeted at Alzheimer's disease useful? 1. Useful for what? Br Med J 300: 1131–1132
Jane Byrne E, Arie T (1990) Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit. Br Med J 300: 1132–1133
Consensus Development Conference (1991) Prophylaxis and Treatment of Osteoporosis. Am J Med 90: 107–110
American College of Physicians (1990) Physicians and the pharmaceutical industry. Ann Intern Med 112: 624–626
Dukes G, Lunde PKM, Melander A, Orme M, Sjöqvist F, Tognoni G, Wesseling H (1990) Clinical pharmacology and primary health care in Europe — A gap to bridge. Eur J Clin Pharmacol 38: 315–318
Anonymous (1990) DURG-Italia. Lancet II: 170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Montanaro, N., Magrini, N., Vaccheri, A. et al. Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989. Eur J Clin Pharmacol 42, 401–408 (1992). https://doi.org/10.1007/BF00280126
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280126